Cargando…

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

OBJECTIVES: The mRNA coronavirus disease 2019 (COVID-19) vaccines have shown high effectiveness in the prevention of symptomatic COVID-19, hospitalization, severe disease and death. Nevertheless, a minority of vaccinated individuals might become infected and experience significant morbidity. Charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brosh-Nissimov, Tal, Orenbuch-Harroch, Efrat, Chowers, Michal, Elbaz, Meital, Nesher, Lior, Stein, Michal, Maor, Yasmin, Cohen, Regev, Hussein, Khetam, Weinberger, Miriam, Zimhony, Oren, Chazan, Bibiana, Najjar, Ronza, Zayyad, Hiba, Rahav, Galia, Wiener-Well, Yonit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261136/ https://www.ncbi.nlm.nih.gov/pubmed/34245907 http://dx.doi.org/10.1016/j.cmi.2021.06.036

Ejemplares similares

Hospitalised patients with breakthrough COVID-19 following vaccination during two distinct waves in Israel, January to August 2021: a multicentre comparative cohort study
por: Brosh-Nissimov, Tal, et al.
Publicado: (2022)

Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort Study
por: Elbaz, Meital, et al.
Publicado: (2022)

The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009–2017
por: Chowers, Michal, et al.
Publicado: (2022)

Initial Effects of the National PCV7 Childhood Immunization Program on Adult Invasive Pneumococcal Disease in Israel
por: Regev-Yochay, Gili, et al.
Publicado: (2014)

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 2015
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021–2022
por: Biran, Roni, et al.
Publicado: (2023)

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

Covid-19 third vaccination during pregnancy: maternal and neonatal outcomes—a retrospective study
por: Rottenstreich, Misgav, et al.
Publicado: (2022)

Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017
por: Belkin, Ana, et al.
Publicado: (2018)

Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19
por: Brosh-Nissimov, Tal, et al.
Publicado: (2021)

Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019
por: Ben-David, Debby, et al.
Publicado: (2023)

Identifying factors affecting latent tuberculosis treatment acceptance among healthcare workers: a retrospective analysis in a tertiary care centre
por: Bar-Meir, Maskit, et al.
Publicado: (2021)

Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
por: Hertz, Tomer, et al.
Publicado: (2023)

Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation
por: Peled, Yael, et al.
Publicado: (2022)

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
por: Maor, Yasmin, et al.
Publicado: (2020)

Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion
por: Mizrahi, Meir, et al.
Publicado: (2009)

Lassa fever: another threat from West Africa
por: Brosh-Nissimov, Tal
Publicado: (2016)

Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk
por: Shavit, Ronen, et al.
Publicado: (2021)

Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
por: Bitterman, Roni, et al.
Publicado: (2021)

Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination
por: Muhsen, Khitam, et al.
Publicado: (2021)

Spotted Fever Group Rickettsioses in Israel, 2010–2019
por: Cohen, Regev, et al.
Publicado: (2021)

Inactivated vaccine Covaxin/BBV152: A systematic review
por: Ahmed, Tousief Irshad, et al.
Publicado: (2022)

Rituximab identified as an independent risk factor for severe PJP: A case-control study
por: Zalmanovich, Anat, et al.
Publicado: (2020)

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
por: Levy, Itzchak, et al.
Publicado: (2022)

Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study
por: Ben Shoham, Assaf, et al.
Publicado: (2023)

Correction: Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study
por: Ben Shoham, Assaf, et al.
Publicado: (2023)

Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose
por: Angel-Korman, Avital, et al.
Publicado: (2021)

Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours
por: Margalit, Ofer, et al.
Publicado: (2022)

2654. International Multi-Center Study Comparing the Effect of Obinutuzumab or Rituximab Treatment in Hematological Patients on COVID-19 Outcomes During the Omicron Surge
por: Shafat, Tal, et al.
Publicado: (2023)

Pityriasis Rosea Following Covaxin (BBV152) Vaccination for COVID-19
por: Singh, Bhabani S. T. P., et al.
Publicado: (2022)

Transplacental transfer of SARS-CoV-2 antibodies in recovered and BNT162b2-vaccinated patients
por: Treger, Sharon, et al.
Publicado: (2022)

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response
por: Peled, Yael, et al.
Publicado: (2021)

241. Molecular patterns of Streptococcus agalactiae (GBS) Strains Associated with Different Clinical Syndromes: Early-Onset Disease in Neonates, Intrauterine Infection, and Vaginal Colonization, an Orthodox Jewish Community (OJC) Residing in Bney Brak
por: Shindler, Yulia, et al.
Publicado: (2019)

Clinical and molecular features of NDM-producing Acinetobacter baumannii in a multicenter study in Israel
por: Adler, Amos, et al.
Publicado: (2023)

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia
por: Tadmor, Tamar, et al.
Publicado: (2021)

Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
por: Shmueli, Einat S., et al.
Publicado: (2021)

Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR)
por: Abu Seir, Rania, et al.
Publicado: (2018)

Early hydrocephalus in Listeria meningitis: Case report and review of the literature
por: Nachmias, B., et al.
Publicado: (2018)

Invasive fungal infections in critically ill COVID-19 patients in a large tertiary university hospital in Israel
por: Ayalon, Oshrat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_boi8jc3p28ontrcbc7vmmreos6